Skip to main content

Advertisement

SpringerLink
Log in

Revisiting articular syndrome in the peri-pandemic COVID-19 era

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Articular syndrome is often the presentation of a person’s various rheumatic or related diseases. It includes both arthralgia and arthritis, with objective signs of joint inflammation defining the latter. This syndromic approach to joint pain enables a scientific method for early diagnosis of common rheumatic conditions without compromising the recognition of uncommon conditions. This review explores common rheumatic conditions associated with articular syndrome, including osteoarthritis, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE). It supports the early differentiation of uncommon but emerging entities such as reactive arthritis (ReA). The aim of the review is to comprehensively overview various forms of articular syndrome to update rheumatologists’ and allied health specialists’ knowledge. Epidemiology, clinical presentations, diagnostic approaches, and therapeutic strategies are discussed in the context of articular syndrome. The challenges emerging in the peri-pandemic COVID-19 era are highlighted. The improved understanding of the spectrum of clinical conditions and disease states presenting with articular syndrome may facilitate early diagnosis, optimal management, and enhanced patient outcomes within the realm of rheumatology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. van Steenbergen HW, da Silva JAP, Huizinga TWJ, van der Helm-van Mil AHM (2018) Preventing progression from arthralgia to arthritis: targeting the right patients. Nat Rev Rheumatol 14(1):32–41. https://doi.org/10.1038/nrrheum.2017.185

    Article  PubMed  Google Scholar 

  2. Kaul A, Gordon C, Crow MK et al (2016) Systemic lupus erythematosus. Nat Rev Dis Primers 2:16039. https://doi.org/10.1038/nrdp.2016.39

    Article  PubMed  Google Scholar 

  3. Di Matteo A, Smerilli G, Cipolletta E et al (2021) Imaging of joint and soft tissue involvement in systemic lupus erythematosus. Curr Rheumatol Rep 23:73. https://doi.org/10.1007/s11926-021-01040-8

    Article  PubMed  PubMed Central  Google Scholar 

  4. Niemantsverdriet E, Dakkak YJ, Burgers LE et al (2020) TREAT early arthralgia to reverse or limit impending exacerbation to rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol. Trials 21:862. https://doi.org/10.1186/s13063-020-04731-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417. https://doi.org/10.1007/s00296-011-1999-3

    Article  PubMed  Google Scholar 

  6. Safiri S, Kolahi AA, Hoy D et al (2019) Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017. Ann Rheum Dis 78:1463–1471. https://doi.org/10.1136/annrheumdis-2019-215920

    Article  PubMed  Google Scholar 

  7. James SL, Abate D, Abate KH et al (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7

    Article  Google Scholar 

  8. Alpízar-Rodríguez D, Pluchino N, Canny G et al (2017) The role of female hormonal factors in the development of rheumatoid arthritis. Rheumatology (Oxford) 56(8):1254–1263. https://doi.org/10.1093/rheumatology/kew318

    Article  PubMed  Google Scholar 

  9. Finckh A, Gilbert B, Hodkinson B et al (2022) Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol 18(10):591–602. https://doi.org/10.1038/s41584-022-00827-y

    Article  PubMed  Google Scholar 

  10. Ahmed S, Grainger R, Santosa A et al (2022) APLAR recommendations on the practice of telemedicine in rheumatology. Int J Rheum Dis 25:247–258. https://doi.org/10.1111/1756-185X.14286

    Article  PubMed  Google Scholar 

  11. Bakland G, Nossent HC (2013) Epidemiology of spondyloarthritis: a review. Curr Rheumatol Rep 15:351. https://doi.org/10.1007/s11926-013-0351-1

    Article  PubMed  Google Scholar 

  12. Strand V, Rao SA, Shillington AC et al (2013) Prevalence of axial spondyloarthritis in United States rheumatology practices: assessment of spondyloarthritis international society criteria versus rheumatology expert clinical diagnosis: ASAS criteria versus clinical diagnosis in axial SpA. Arthritis Care Res 65:1299–1306. https://doi.org/10.1002/acr.21994

    Article  Google Scholar 

  13. Zeng Q, Chen R, Darmawan J et al (2008) Rheumatic diseases in China. Arthritis Res Ther 10:R17. https://doi.org/10.1186/ar2368

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kiltz U, Baraliakos X, Karakostas P et al (2012) Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res 64:1415–1422. https://doi.org/10.1002/acr.21688

    Article  Google Scholar 

  15. Gupta L, Naveen R, Ahmed S et al (2021) Juvenile reactive arthritis and other spondyloarthritides of childhood: a 28-year experience from India. Mediterr J Rheumatol 32:338–344. https://doi.org/10.31138/mjr.32.4.338

    Article  PubMed  PubMed Central  Google Scholar 

  16. Dimmick S, Hayter C, Linklater J (2022) Acute calcific periarthritis-a commonly misdiagnosed pathology. Skelet Radiol 51:1553–1561. https://doi.org/10.1007/s00256-022-04006-8

    Article  Google Scholar 

  17. Neviaser AS, Neviaser RJ (2011) Adhesive capsulitis of the shoulder. J Am Acad Orthop Surg 19:536–542. https://doi.org/10.5435/00124635-201109000-00004

    Article  PubMed  Google Scholar 

  18. Neviaser JS (1945) Adhesive capsulitis of the shoulder: a study of the pathological findings in periarthritis of the shoulder. JBJS 27:211

    Google Scholar 

  19. Wright V, Haq AM (1976) Periarthritis of the shoulder. I. Aetiological considerations with particular reference to personality factors. Ann Rheum Dis 35:213–219

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. D’Orsi GM, Via AG, Frizziero A, Oliva F (2012) Treatment of adhesive capsulitis: a review. Muscles Ligaments Tendons J 2:70–78

    PubMed  PubMed Central  Google Scholar 

  21. Tzeng C-Y, Chiang H-Y, Huang C-C et al (2019) The impact of pre-existing shoulder diseases and traumatic injuries of the shoulder on adhesive capsulitis in adult population: A population-based nested case-control study. Medicine 98:e17204. https://doi.org/10.1097/MD.0000000000017204

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sarasua SM, Floyd S, Bridges WC, Pill SG (2021) The epidemiology and etiology of adhesive capsulitis in the U.S. Medicare population. BMC Musculoskelet Disord 22:828. https://doi.org/10.1186/s12891-021-04704-9

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ascani C, Passaretti D, Scacchi M et al (2021) Can adhesive capsulitis of the shoulder be a consequence of COVID-19? Case series of 12 patients. J Shoulder Elbow Surg 30:e409–e413. https://doi.org/10.1016/j.jse.2021.04.024

    Article  PubMed  PubMed Central  Google Scholar 

  24. Pandey V, Madi S (2021) Clinical guidelines in the management of frozen shoulder: an update! Indian J Orthop 55:299–309. https://doi.org/10.1007/s43465-021-00351-3

    Article  PubMed  PubMed Central  Google Scholar 

  25. Rangan A, Brealey SD, Keding A et al (2020) Management of adults with primary frozen shoulder in secondary care (UK FROST): a multicentre, pragmatic, three-arm, superiority randomised clinical trial. Lancet 396:977–989. https://doi.org/10.1016/S0140-6736(20)31965-6

    Article  CAS  PubMed  Google Scholar 

  26. Maru D, Mulla E (2020) Rheumatoid arthritis. InnovAiT 13:13–20. https://doi.org/10.1177/1755738019884346

    Article  Google Scholar 

  27. Pujalte GGA, Albano-Aluquin SA (2015) Differential diagnosis of polyarticular arthritis. Am Family Physician 92:35–41

    Google Scholar 

  28. Sieper J, Rudwaleit M, Baraliakos X et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:ii1–ii44. https://doi.org/10.1136/ard.2008.104018

  29. Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52:1000–1008. https://doi.org/10.1002/art.20990

    Article  PubMed  Google Scholar 

  30. Calin A, Porta J, Fries JF, Schurman DJ (1977) Clinical history as a screening test for ankylosing spondylitis. JAMA 237(24):2613–2614.

  31. Linden SVD, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum 27:361–368. https://doi.org/10.1002/art.1780270401

    Article  PubMed  Google Scholar 

  32. Poddubnyy D, Callhoff J, Spiller I et al (2018) Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care. RMD Open 4:e000825. https://doi.org/10.1136/rmdopen-2018-000825

    Article  PubMed  PubMed Central  Google Scholar 

  33. Braun J, Inman R (2010) Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis. Ann Rheum Dis 69:1264–1268. https://doi.org/10.1136/ard.2010.130559

    Article  PubMed  Google Scholar 

  34. Dougados M, Linden SVD, Juhlin R et al (1991) The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227. https://doi.org/10.1002/art.1780341003

    Article  CAS  PubMed  Google Scholar 

  35. Benjamin M, Moriggl B, Brenner E et al (2004) The “enthesis organ” concept: why enthesopathies may not present as focal insertional disorders. Arthritis Rheum 50:3306–3313. https://doi.org/10.1002/art.20566

    Article  CAS  PubMed  Google Scholar 

  36. Heuft-Dorenbosch L (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62:127–132. https://doi.org/10.1136/ard.62.2.127

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Healy PJ, Helliwell PS (2008) Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 59:686–691. https://doi.org/10.1002/art.23568

    Article  PubMed  Google Scholar 

  38. Maksymowych WP, Mallon C, Morrow S et al (2009) Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis 68:948–953. https://doi.org/10.1136/ard.2007.084244

    Article  CAS  PubMed  Google Scholar 

  39. Mathew AJ, Østergaard M (2020) Magnetic resonance imaging of enthesitis in spondyloarthritis, including psoriatic arthritis—status and recent advances. Front Med 7:296. https://doi.org/10.3389/fmed.2020.00296

    Article  Google Scholar 

  40. Poddubnyy D, Jadon DR, Van Den Bosch F et al (2021) Axial involvement in psoriatic arthritis: an update for rheumatologists. Semin Arthritis Rheum 51:880–887. https://doi.org/10.1016/j.semarthrit.2021.06.006

    Article  PubMed  Google Scholar 

  41. Feld J, Ye JY, Chandran V et al (2021) Axial Disease in Psoriatic arthritis: the presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort. Semin Arthritis Rheum 51:464–468. https://doi.org/10.1016/j.semarthrit.2021.03.007

    Article  PubMed  Google Scholar 

  42. Gladman DD (2021) Axial psoriatic arthritis. Curr Rheumatol Rep 23:35. https://doi.org/10.1007/s11926-021-00999-8

    Article  PubMed  Google Scholar 

  43. Aydin SZ, Kucuksahin O, Kilic L et al (2018) Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life. Clin Rheumatol 37:3443–3448. https://doi.org/10.1007/s10067-018-4173-4

    Article  PubMed  Google Scholar 

  44. Salvarani IG, Vlachonikolis DC (2001) Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313. https://doi.org/10.1080/003655201317097173

    Article  CAS  PubMed  Google Scholar 

  45. Lanna CCD, Ferrari MDLA, Rocha SL et al (2008) A cross-sectional study of 130 Brazilian patients with Crohn’s disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations. Clin Rheumatol 27:503–509. https://doi.org/10.1007/s10067-007-0797-5

    Article  PubMed  Google Scholar 

  46. Rudwaleit M, Van Der Heijde D, Landewe R et al (2011) The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25–31. https://doi.org/10.1136/ard.2010.133645

    Article  CAS  PubMed  Google Scholar 

  47. Feldtkeller E, Khan M, Van Der Heijde D et al (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61–66. https://doi.org/10.1007/s00296-002-0237-4

    Article  PubMed  Google Scholar 

  48. Garrido-Cumbrera M, Navarro-Compán V, Bundy C et al (2022) Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis. Rheumatology 61:705–712. https://doi.org/10.1093/rheumatology/keab369

    Article  PubMed  Google Scholar 

  49. Ortolan A, Van Lunteren M, Ramiro S et al (2018) Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort. Arthritis Res Ther 20:218. https://doi.org/10.1186/s13075-018-1705-x

    Article  PubMed  PubMed Central  Google Scholar 

  50. Rudwaleit M, Claudepierre P, Wordsworth P et al (2009) Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis. J Rheumatol 36:801–808. https://doi.org/10.3899/jrheum.081048

    Article  CAS  PubMed  Google Scholar 

  51. Deodhar A, Van Der Heijde D, Gensler LS et al (2020) Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial. The Lancet 395:53–64. https://doi.org/10.1016/S0140-6736(19)32971-X

    Article  CAS  Google Scholar 

  52. Deodhar A, Gill T, Magrey M (2023) Human leukocyte antigen B27-negative axial spondyloarthritis: what do we know? ACR Open Rheumatol 5:333–344. https://doi.org/10.1002/acr2.11555

    Article  PubMed  PubMed Central  Google Scholar 

  53. Rudwaleit M, Haibel H, Baraliakos X et al (2009) The early disease stage in axial spondylarthritis: results from the German spondyloarthritis inception cohort. Arthritis Rheum 60:717–727. https://doi.org/10.1002/art.24483

    Article  CAS  PubMed  Google Scholar 

  54. Queiro R, Morante I, Cabezas I, Acasuso B (2016) HLA-B27 and psoriatic disease: a modern view of an old relationship. Rheumatology 55:221–229. https://doi.org/10.1093/rheumatology/kev296

    Article  CAS  PubMed  Google Scholar 

  55. Liao H-T, Lin K-C, Chang Y-T et al (2008) Human leukocyte antigen and clinical and demographic characteristics in psoriatic arthritis and psoriasis in Chinese patients. J Rheumatol 35:891–895

    PubMed  Google Scholar 

  56. Parida JR, Kumar S, Ahmed S et al (2021) Reactive arthritis and undifferentiated peripheral spondyloarthritis share human leucocyte antigen B27 subtypes and serum and synovial fluid cytokine profiles. Rheumatology 60:3004–3011. https://doi.org/10.1093/rheumatology/keaa746

    Article  CAS  PubMed  Google Scholar 

  57. Braun J, Sieper J (2023) Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis. RMD Open 9:e003102. https://doi.org/10.1136/rmdopen-2023-003102

    Article  PubMed  PubMed Central  Google Scholar 

  58. Zhang S, Wang Y, Peng L et al (2020) Comparison of clinical features in HLA-B27 positive and negative patients with axial spondyloarthritis: results from a cohort of 4,131 patients. Front Med 7:609562. https://doi.org/10.3389/fmed.2020.609562

    Article  Google Scholar 

  59. Lambert RGW, Bakker PAC, Van Der Heijde D et al (2016) Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis 75:1958–1963. https://doi.org/10.1136/annrheumdis-2015-208642

    Article  PubMed  Google Scholar 

  60. Ward MM, Deodhar A, Gensler LS et al (2019) 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res (Hoboken) 71:1285–1299. https://doi.org/10.1002/acr.24025

    Article  PubMed  Google Scholar 

  61. Ramiro S, Nikiphorou E, Sepriano A et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82:19–34. https://doi.org/10.1136/ard-2022-223296

    Article  PubMed  Google Scholar 

  62. Gossec L, Baraliakos X, Kerschbaumer A et al (2020) EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 79:700–712. https://doi.org/10.1136/annrheumdis-2020-217159

    Article  PubMed  Google Scholar 

  63. Bekaryssova D, Joshi M, Gupta L et al (2022) Knowledge and perceptions of reactive arthritis diagnosis and management among healthcare workers during the COVID-19 pandemic: online survey. J Korean Med Sci 37:e355. https://doi.org/10.3346/jkms.2022.37.e355

    Article  PubMed  PubMed Central  Google Scholar 

  64. Aggarwal A, Misra R, Chandrasekhar S et al (1997) Is undifferentiated seronegative spondyloarthropathy a forme fruste of reactive arthritis? Rheumatology 36:1001–1004. https://doi.org/10.1093/rheumatology/36.9.1001

    Article  CAS  Google Scholar 

  65. Chowdhury AC, Chaurasia S, Mishra SK et al (2017) IL-17 and IFN-γ producing NK and γδ-T cells are preferentially expanded in synovial fluid of patients with reactive arthritis and undifferentiated spondyloarthritis. Clin Immunol 183:207–212. https://doi.org/10.1016/j.clim.2017.03.016

    Article  CAS  PubMed  Google Scholar 

  66. Singh AK, Misra R, Aggarwal A (2011) Th-17 associated cytokines in patients with reactive arthritis/undifferentiated spondyloarthropathy. Clin Rheumatol 30:771–776. https://doi.org/10.1007/s10067-010-1646-5

    Article  PubMed  Google Scholar 

  67. Ahmed S, Dubey D, Chowdhury A et al (2019) Nuclear magnetic resonance-based metabolomics reveals similar metabolomics profiles in undifferentiated peripheral spondyloarthritis and reactive arthritis. Int J Rheum Dis 22:725–733. https://doi.org/10.1111/1756-185X.13490

    Article  CAS  PubMed  Google Scholar 

  68. Ahmed S, Mishra R, Mahapatra S et al (2023) 16S metagenomics reveals unique diversity and novel gut microbiota associated with reactive arthritis. SSRN. http://dx.doi.org/10.2139/ssrn.4455358

  69. Grinnell M, Ogdie A, Wipfler K, Michaud K (2020) Probiotic use and psoriatic arthritis disease activity. ACR Open Rheumatol 2:330–334. https://doi.org/10.1002/acr2.11143

    Article  PubMed  PubMed Central  Google Scholar 

  70. Santiago MB, Galvão V, Ribeiro DS et al (2015) Severe Jaccoud’s arthropathy in systemic lupus erythematosus. Rheumatol Int 35:1773–1777. https://doi.org/10.1007/s00296-015-3351-9

    Article  CAS  PubMed  Google Scholar 

  71. Gerlag DM, Raza K, Van Baarsen LGM et al (2012) EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis 71:638–641. https://doi.org/10.1136/annrheumdis-2011-200990

    Article  PubMed  Google Scholar 

  72. Van Steenbergen HW, Mangnus L, Reijnierse M et al (2016) Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis. Ann Rheum Dis 75:1824–1830. https://doi.org/10.1136/annrheumdis-2015-208138

    Article  PubMed  Google Scholar 

  73. Van Steenbergen HW, Aletaha D, Beaart-van De Voorde LJJ et al (2017) EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Ann Rheum Dis 76:491–496. https://doi.org/10.1136/annrheumdis-2016-209846

    Article  PubMed  Google Scholar 

  74. Zoma A (2004) Musculoskeletal involvement in systemic lupus erythematosus. Lupus 13:851–853. https://doi.org/10.1191/0961203303lu2021oa

    Article  CAS  PubMed  Google Scholar 

  75. Aringer M, Costenbader K, Daikh D et al (2019) 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol 71:1400–1412. https://doi.org/10.1002/art.40930

    Article  PubMed  PubMed Central  Google Scholar 

  76. Bjelle A (1992) Arthritis in the elderly. Z Rheumatol 51:295–300

    CAS  PubMed  Google Scholar 

  77. Kobak S, Bes C (2018) An autumn tale: geriatric rheumatoid arthritis. Ther Adv Musculoskelet Dis 10:3–11. https://doi.org/10.1177/1759720X17740075

    Article  Google Scholar 

  78. Bayrak ED, Aktas I (2023) Efficacy and gastrointestinal tolerability of methotrexate in late-onset rheumatoid arthritis patients: a prospective cohort study. Egypt Rheumatol Rehabil 50:8. https://doi.org/10.1186/s43166-023-00178-w

    Article  Google Scholar 

  79. Parperis K, Constantinidou A, Panos G (2021) Paraneoplastic arthritides: insights to pathogenesis, diagnostic approach, and treatment. J Clin Rheumatol 27:e505–e509. https://doi.org/10.1097/RHU.0000000000001202

    Article  PubMed  Google Scholar 

  80. Karmacharya P, Donato AA, Aryal MR et al (2016) RS3PE revisited: a systematic review and meta-analysis of 331 cases. Clin Exp Rheumatol 34:404–415

    PubMed  Google Scholar 

  81. Manger B, Schett G (2014) Palmar fasciitis and polyarthritis syndrome—systematic literature review of 100 cases. Semin Arthritis Rheum 44:105–111. https://doi.org/10.1016/j.semarthrit.2014.03.005

    Article  PubMed  Google Scholar 

  82. Pineda C, Martínez-Lavín M (2013) Hypertrophic osteoarthropathy. Rheum Dis Clin N Am 39:383–400. https://doi.org/10.1016/j.rdc.2013.02.008

    Article  Google Scholar 

  83. Betsinger TK, Scott AB (2023) Back-to-back: the co-occurrence of DISH and ankylosing spondylitis from early modern Poland. Int J Paleopathol 40:1–6. https://doi.org/10.1016/j.ijpp.2022.11.002

    Article  PubMed  Google Scholar 

  84. Mader R, Verlaan J-J, Eshed I et al (2017) Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next. RMD Open. https://doi.org/10.1136/rmdopen-2017-000472

    Article  PubMed  Google Scholar 

  85. Kuperus JS, Mohamed Hoesein FAA, de Jong PA, Verlaan JJ (2020) Diffuse idiopathic skeletal hyperostosis: etiology and clinical relevance. Best Pract Res Clin Rheumatol 34:101527. https://doi.org/10.1016/j.berh.2020.101527

    Article  PubMed  Google Scholar 

  86. Mader R (2005) Current therapeutic options in the management of diffuse idiopathic skeletal hyperostosis. Expert Opin Pharmacother 6:1313–1318. https://doi.org/10.1517/14656566.6.8.1313

    Article  CAS  PubMed  Google Scholar 

  87. Bekaryssova D, Yessirkepov M, Zimba O et al (2022) Reactive arthritis before and after the onset of the COVID-19 pandemic. Clin Rheumatol 41:1641–1652. https://doi.org/10.1007/s10067-022-06120-3

    Article  PubMed  PubMed Central  Google Scholar 

  88. Ahmed S, Zimba O, Gasparyan AY (2021) COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol 40:2611–2619. https://doi.org/10.1007/s10067-021-05691-x

    Article  PubMed  PubMed Central  Google Scholar 

  89. Shah S, Danda D, Kavadichanda C et al (2020) Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int 40:1539–1554. https://doi.org/10.1007/s00296-020-04639-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Fedorchenko Y, Zimba O (2023) Long COVID in autoimmune rheumatic diseases. Rheumatol Int 43:1197–1207. https://doi.org/10.1007/s00296-023-05319-0

    Article  PubMed  PubMed Central  Google Scholar 

  91. Baimukhamedov C, Mirakhmedova K, Dossybayeva G (2023) Long COVID: the time has come for globally acceptable definitions. Rheumatol Int 43(11):2155–2156. https://doi.org/10.1007/s00296-023-05414-2

    Article  PubMed  PubMed Central  Google Scholar 

  92. Baimukhamedov C (2023) How long is long COVID. Int J Rheum Dis 26:190–192. https://doi.org/10.1111/1756-185X.14494

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors duly acknowledge the continuing support and editing guidance of Prof Armen Yuri Gasparyan.

Funding

None

Author information

Authors and Affiliations

  1. Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan

    Dana Bekaryssova

  2. Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India

    Prakashini Mruthyunjaya Vijaya & Sakir Ahmed

  3. Department of Orthopedics, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India

    Suhas Sondur

  4. Department of Clinical Rheumatology and Immunology, University Hospital in Krakow, Kraków, Poland

    Olena Zimba

  5. National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

    Olena Zimba

  6. Department of Internal Medicine N2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

    Olena Zimba

Authors
  1. Dana Bekaryssova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prakashini Mruthyunjaya Vijaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sakir Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Suhas Sondur
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Olena Zimba
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All co-authors contributed substantially to the concept, formulation, searches of relevant articles, and revisions. They approve the final version of the manuscript and take full responsibility for all aspects of the work.

Corresponding author

Correspondence to Dana Bekaryssova.

Ethics declarations

Conflict of interest

None

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bekaryssova, D., Mruthyunjaya Vijaya, P., Ahmed, S. et al. Revisiting articular syndrome in the peri-pandemic COVID-19 era. Rheumatol Int 43, 2157–2166 (2023). https://doi.org/10.1007/s00296-023-05459-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-023-05459-3

Keywords

Search

Navigation